Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements.
Citation
Guinn, B.A., Greiner, J., Schmitt, M., Mills, K.I. (2009) 'Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements' Blood 113 (5):1203-4Publisher
HighWire PressJournal
BloodPubMed ID
19179477Additional Links
http://bloodjournal.hematologylibrary.org/content/113/5/1203.longType
ArticleLanguage
enISSN
1528-0020Sponsors
Leukaemia and Lymphoma Researchae974a485f413a2113503eed53cd6c53
10.1182/blood-2008-09-178848
Scopus Count
Collections
Related articles
- Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches.
- Authors: Greiner J, Schmitt M, Li L, Giannopoulos K, Bosch K, Schmitt A, Dohner K, Schlenk RF, Pollack JR, Dohner H, Bullinger L
- Issue date: 2006 Dec 15
- The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis?
- Authors: Mason KD, Juneja SK, Szer J
- Issue date: 2006 Mar
- Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
- Authors: Jankovic D, Gorello P, Liu T, Ehret S, La Starza R, Desjobert C, Baty F, Brutsche M, Jayaraman PS, Santoro A, Mecucci C, Schwaller J
- Issue date: 2008 Jun 15
- Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen.
- Authors: Ochsenreither S, Majeti R, Schmitt T, Stirewalt D, Keilholz U, Loeb KR, Wood B, Choi YE, Bleakley M, Warren EH, Hudecek M, Akatsuka Y, Weissman IL, Greenberg PD
- Issue date: 2012 Jun 7
- The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells.
- Authors: Almstedt M, Blagitko-Dorfs N, Duque-Afonso J, Karbach J, Pfeifer D, Jäger E, Lübbert M
- Issue date: 2010 Jul